Credit Suisse’s New Frontier Health Corporation Ordinary Shares NFH Stock Holding History

Credit Suisse’s Portfolio NFH Stock Details NFH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-475,215	Closed	-$5.45M	–	4553
2021 Q4	$5.45M	Buy	475,215 +285,096	+150%	+$3.21M	﹤0.01%	1952
2021 Q3	$2.13M	Buy	190,119 +102,626	+117%	+$1.14M	﹤0.01%	2762
2021 Q2	$983K	Sell	87,493 -57,711	-40%	-$647K	﹤0.01%	3401
2021 Q1	$1.64M	Buy	145,204 +83,752	+136%	+$851K	﹤0.01%	2964
2020 Q4	$528K	Hold	61,452	–	–	﹤0.01%	3773
2020 Q3	$469K	Buy	61,452 +15,652	+34%	+$128K	﹤0.01%	3436
2020 Q2	$379K	Buy	+45,800	New	+$372K	﹤0.01%	3468

Other funds holding NFH

Vivo Capital Palo Alto, California $1.1B AUM 799.93% 1-Year Est. Return

MCP

Maso Capital Partners Hong Kong $60.9M AUM 0.32% 1-Year Est. Return

Credit Suisse's NFH Position: Q1 2022 in Review

Credit Suisse sold out of New Frontier Health Corporation Ordinary Shares (NFH) in Q1 2022, closing a stake of 475,215 shares — an estimated $5.45M sold.

Credit Suisse first reported a position in NFH in Q2 2020 and held it in 7 quarters. The position peaked at $5.45M in Q4 2021. 2 funds tracked by Wall St. Rank hold NFH as of Q1 2022.

Credit Suisse reported no remaining New Frontier Health Corporation Ordinary Shares position as of Q1 2022 after selling out during the quarter.
Credit Suisse sold 475,215 New Frontier Health Corporation Ordinary Shares shares in Q1 2022, an estimated $5.45M.
Credit Suisse first reported a position in New Frontier Health Corporation Ordinary Shares in Q2 2020 and held it in 7 quarters.
Credit Suisse's New Frontier Health Corporation Ordinary Shares position peaked at $5.45M in Q4 2021.
2 funds tracked by Wall St. Rank held New Frontier Health Corporation Ordinary Shares as of Q1 2022.

Based on Credit Suisse's 13F filing for Q1 2022, filed 16 May 2022.